Eighty states, cities, counties, school boards and unions have joined litigation in a New Jersey district court against the three major pharmacy middlemen.
,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...
Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...
4h
IN a world with soaring obesity rates, fat jabs have arrived and taken the world of the rich and beautiful by storm. The injections have allegedly helped celebrities like Elon Musk, Sharon ...
Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.
Studies show that people with obesity are more likely to find that ill health affects their productivity and attendance at work.
The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...
Providing coverage for weight-loss drugs such as Wegovy and Ozempic is forcing employers to make some critical decisions.
Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott’s ...
Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...
Rapper Fat Joe— who at his heaviest was 470 lbs. — said he watches his portions, thanks to a little help from Ozempic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback